Phase II multicenter study to analyze the predictive value of fusion gene TMPRSS2-ETS assessed both in tumor and blood sample, as a marker of response to enzalutamide in patients with metastatic castration resistant prostate cancer (CRPC) pre-chemotherapy

Fernández Calvo, Ovidio; Vázquez Estévez, Sergio

Estatísticas

Estatísticas

Ver Estatísticas de uso

Identificadores

Identificadores

URI: http://hdl.handle.net/20.500.11940/722

ISSN: 0732-183X

Rexistro completo

Servizos

Servizos

RIS

Mendeley

Linksolver

Data de publicación

2015

Título da revista

Journal Of Clinical Oncology

Tipo de contido

Publicación de congreso